1
|
Komotar RJ, Schmidt JM, Starke RM,
Claassen J, Wartenberg KE, Lee K, Badjatia N, Connolly ES Jr and
Mayer SA: Resuscitation and critical care of poor-grade
subarachnoid hemorrhage. Neurosurgery. 64:397–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kameda K, Kikkawa Y, Hirano M, Matsuo S,
Sasaki T and Hirano K: Combined argatroban and anti-oxidative
agents prevents increased vascular contractility to thrombin and
other ligands after subarachnoid haemorrhage. Br J Pharmacol.
165:106–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hirano K: The roles of
proteinase-activated receptors in the vascular physiology and
pathophysiology. Arterioscler Thromb Vasc Biol. 27:27–36. 2007.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Qi J, Zhang L, Jia W, Zhang J and Wu Z:
Diffuse cerebral vasospasm after resection of schwannoma: A case
report. Neuropsychiatr Dis Treat. 11:317–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Eisenhut M: The evidence for a role of
vasospasm in the pathogenesis of cerebral malaria. Malar J.
14:4052015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Vecchione C, Frati A, Di Pardo A, Cifelli
G, Carnevale D, Gentile MT, Carangi R, Landolfi A, Carullo P,
Bettarini U, et al: Tumor necrosis factor-alpha mediates
hemolysis-induced vasoconstriction and the cerebral vasospasm
evoked by subarachnoid hemorrhage. Hypertension. 54:150–156. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Jayaraman T, Paget A, Shin YS, Li X, Mayer
J, Chaudhry H, Niimi Y, Silane M and Berenstein A:
TNF-alpha-mediated inflammation in cerebral aneurysms: A potential
link to growth and rupture. Vasc Health Risk Manag. 4:805–817.
2008.PubMed/NCBI
|
8
|
Hanafy KA, Stuart RM, Khandji AG, Connolly
ES, Badjatia N, Mayer SA and Schindler C: Relationship between
brain interstitial fluid tumor necrosis factor-α and cerebral
vasospasm after aneurysmal subarachnoid hemorrhage. J Clin
Neurosci. 17:853–856. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Raslan F, Albert-Weißenberger C,
Westermaier T, Saker S, Kleinschnitz C and Lee JY: A modified
double injection model of cisterna magna for the study of delayed
cerebral vasospasm following subarachnoid hemorrhage in rats. Exp
Transl Stroke Med. 4:232012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Raslan F, Schwarz T, Meuth SG, Austinat M,
Bader M, Renné T, Roosen K, Stoll G, Sirén AL and Kleinschnitz C:
Inhibition of bradykinin receptor B1 protects mice from focal brain
injury by reducing blood-brain barrier leakage and inflammation. J
Cereb Blood Flow Metab. 30:1477–1486. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Endo S, Branson PJ and Alksne JF:
Experimental model of symptomatic vasospasm in rabbits. Stroke.
19:1420–1425. 1988. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang QS and Li G: Recent advance in
pathogenesis of cerebral vasospasm after subarachnoid hemorrhage.
Chinese Journal of Neuromedicine. 4:422–425. 2013.
|
13
|
Ma Y, Liu AM, Cai WQ and Hu Z: Granulocyte
colony stimulating factor for hemorrhage rats after the influence
of the expression of tumor necrosis factor alpha and nerve
protective effect. Chinese Journal of Experimental Surgery.
28:3132011.
|
14
|
Kai Y, Maeda Y, Sasaki T, Kanaide H and
Hirano K: Basic and translational research on proteinase-activated
receptors: The role of thrombin receptor in cerebral vasospasm in
subarachnoid hemorrhage. J Pharmacol Sci. 108:426–432. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Aoki T, Kataoka H, Shimamura M, Nakagami
H, Wakayama K, Moriwaki T, Ishibashi R, Nozaki K, Morishita R and
Hashimoto N: NF-kappaB is a key mediator of cerebral aneurysm
formation. Circulation. 116:2830–2840. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cahill J, Calvert JW and Zhang JH:
Mechanisms of early brain injury after subarachnoid hemorrhage. J
Cereb Blood Flow Metab. 26:1341–1353. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhou ML, Shi JX, Hang CH, Cheng HL, Qi XP,
Mao L, Chen KF and Yin HX: Potential contribution of nuclear
factor-kappaB to cerebral vasospasm after experimental subarachnoid
hemorrhage in rabbits. J Cereb Blood Flow Metab. 27:1583–1592.
2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Mbebi C, Rohn T, Doyennette MA, Chevessier
F, Jandrot-Perrus M, Hantaï D and Verdière-Sahuqué M: Thrombin
receptor induction by injury-related factors in human skeletal
muscle cells. Exp Cell Res. 263:77–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chieng-Yane P, Bocquet A, Létienne R,
Bourbon T, Sablayrolles S, Perez M, Hatem SN, Lompré AM, Le Grand B
and David-Dufilho M: Protease-activated receptor-1 antagonist F
16618 reduces arterial restenosis by down-regulation of tumor
necrosis factor α and matrix metalloproteinase 7 expression,
migration and proliferation of vascular smooth muscle cells. J
Pharmacol Exp Ther. 336:643–651. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu C and Tang JW: Expression of tumor
necrosis factor-α in rats with severe acute pancreatitis
complicated with acute renal injury. Chinese Journal of
Experimental Surgery. 30:26–28. 2013.
|
21
|
Hirano K and Hirano M: Current perspective
on the role of the thrombin receptor in cerebral vasospasm after
subarachnoid hemorrhage. J Pharmacol Sci. 114:127–133. 2010.
View Article : Google Scholar : PubMed/NCBI
|